ArticleMolecular medicine reports2026
[Corrigendum] Coenzyme Q10 alleviates sevoflurane‑induced neuroinflammation by regulating the levels of apolipoprotein E and phosphorylated tau protein in mouse hippocampal neurons.
Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of the above article, a concerned author drew to the authors' attention that they had apparently used an inappropriate antibody in their study: In the Materials and methods section, the authors had reported the use of Abcam's recombinant antibody against plant homeodomain (PHD) finger protein 1 (a.k.a. PHF1; cat. no. ab184951) to probe for the unrelated protein, tau paired helical filaments (PHFs). The authors acknowledged that they had made a methodological error: They were intending to detect tau phosphorylation at Ser396/404, but mistakenly had used the antibody against PHD finger protein 1 (cat. no. ab184951; Abcam); as a result, the western blot results shown in Figs. 3 and 7 for protein PHF1 were invalid. This error went unnoticed since the two antibodies shared the same abbreviation (PHF1), and the banding patterns obtained with the incorrect antibody appeared similar in trend to what the authors had expected to have found, which unfortunately masked the mistake during their internal data review. The Editor instructed the authors to repeat the PHF1 western blot experiments using the correct PHF1 antibody (Tau‑pSer396/404; cat. no. 87061‑1‑RR; Proteintech Group, Inc.). The new experiments yielded reproducible and valid results, and the authors have replaced the original data relating to protein PHF1 in Figs. 3 and 7; the revised versions of these figures are shown on the next page. Note that these errors did not affect the results or the main conclusions reported in the study. All the authors approve of the publication of this corrigendum, and are grateful to the Editor of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.